Drawing for SOCORRO PHARMA

USPTO serial 87373560

SOCORRO PHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GOODMAN, WENDY BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOCORRO PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca McCurry

REBECCA MCCURRY PIRKEY BARBER PLLC600 CONGRESS AVENUE, SUITE 2120AUSTIN, TX 78701UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antivirals; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for use in dermatology; antifungal preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for ophthalmological use; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of pain and inflammation; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, circulatory, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations, substances and biosimilars for use in chemotherapy; pharmaceutical and veterinary preparations, substances and biosimilars for use in urology; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of stress; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of diabetes; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of joint disorders; pharmaceutical and veterinary preparations, substances and biosimilars for controlling insulin levels; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of hypertension, hypercholesteremia, and hyperlipidemia; pharmaceutical preparations, substances and biosimilars for the prevention, treatment and alleviation of angina; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of sexually transmitted diseases; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of sleep disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars, namely, fibrinolytic or thrombolytic agents; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of migraines; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of fungal infections; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of dermatophytosis, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of ophthalmic and ocular disorders, diseases, conditions and ailments; ophthalmic; pharmaceuticals, namely, contact wetting and cleaning lens solutions, contact lens disinfectants, eye drops, solutions, gels, lubricants and ointments used for moisturizing the eye and to treat conditions such as dry eyes, allergies, inflammation, redness and itchy eyes; ophthalmic diagnostic test strips; viscoelastic preparations used in ophthalmic surgery; nasal spray preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of erectile and sexual dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars used in dialysis; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of epilepsy; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergies; pharmaceutical and veterinary preparations, namely, injectable contraceptives; oral and chemical contraceptives; pharmaceutical and veterinary preparations, substances and biosimilars, namely, psychotropics; pharmaceutical preparations, substances and biosimilars for the treatment of gout; antibacterial pharmaceuticals and veterinary preparations, substances and biosimilars; pharmaceuticals and veterinary preparations, substances and biosimilars, namely, antimetics and emetics; anesthetics for surgical and non-surgical use; analgesics; sedatives; tranquilizers; antiparasitics; cough treatment preparations; muscle relaxants; steroids; appetite suppressants and stimulants; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of Lyme disease; hormonal preparations; anthelmintics; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of rheumatoid arthritis and arthritis; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of bacterial infections; veterinary vaccines; diagnostic preparations for veterinary purposes; stem cells for veterinary purposes; enzyme preparations for veterinary purposes; a full line of vitamins, minerals, and nutritional and dietary supplements for human consumption; Albumin dietary supplements; Alginate dietary supplements; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Casein dietary supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement drink mixes; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplemental drinks; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for pets; Dietary supplements for treatment of claustrophobia; Dietary supplements for urinary health; Dietary supplements in the nature of weight loss powders; Dietary supplements; dietary supplements featuring grape seed extract, beta carotene, bilberry, black cohosh, cayenne, Garcinia Cambogia extract, garlic oil, coenzyme Q10, collagen, cranberry, echinacea, elderberry extract, garlic, ginkgo biloba, ginseng, goldenseal, green tea, pine extracts, guarana, guggulsterone, gymnema, hawthorn, milk thistle, bark of Pinus pinaster, pygeum, saw palmetto, stevia, St. John's wort, yohimbe, melatonin, notoginseng, aloe vera, garlic oil, fish oil, deep fish oil, namely, deep fish oil for lowering cholesterol and blood pressure, pumpkin seed oil, lecithin, liquid calcium, lysine, squalene, cow colostrums, marine oil, namely, marine oil for preventing or slowing skin from aging, evening primrose oil, sea buckthorn oil, pine oil, safflower oil, bee propolis, placenta, RNA/DNA, namely, RNA/DNA for improving the immune system of human body, spirulina, shark cartilage, natural rose hip oil, soy lecithin, coral calcium, multiamino acid, nucleic acid DNA/RNA, fish protein, natural HCA, noni extract, red dehydroepiandrosterone, DHA-docosahexaenoic acid, EPA eicosapentaenoic acid, ginger extract, multi vitamins, and/or PSP polysaccharide peptide; Enzyme dietary supplements; Enzyme food supplements; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Food supplements, namely, anti-oxidants; Food supplements; Fruit-based meal replacement bars for treating vitamin B12 deficiency that causes fatigue; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Glucose dietary supplements; Ground flaxseed fiber for use as a dietary supplement; Gummy vitamins; Health food supplements; Herbal supplements for sleeping problems; Herbal supplements; Homeopathic supplements; Hormone replacement therapy preparations; Hormones; Human growth hormone; Lecithin dietary supplements; Lecithin for use as a dietary supplement; Linseed dietary supplements; Linseed oil dietary supplements; Liquid herbal supplements; Liquid nutritional supplement; Liquid protein supplements; Liquid vitamin supplements; Liquid vitamin supplements; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral supplements featuring Boron, Calcium, Chromium, Copper, Iodine, Iron, Magnesium, Manganese, Molybdenum, Phosphorus, Potassium, Selenium, Silicon, Vanadium, and/or Zinc; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed hormone preparations; Mixed vitamin preparations; Multi-vitamin preparations; Natural dietary supplements for treatment of claustrophobia; Natural herbal supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Natural supplements for treating candida; Natural supplements for treating depression and anxiety; Natural supplements for treating erectile dysfunction; Non-medicated additives for animal feed for use as nutritional supplements; Nopal cactus juice for use as a nutritional supplement; Nutraceuticals for use as a dietary supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritional supplements, namely, probiotic compositions; Nutritional supplements; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pollen dietary supplements; Powdered fruit-flavored dietary supplement drink mix; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix; Prenatal vitamins; Probiotic supplements; Propolis dietary supplements; Protein dietary supplements; Protein supplement shakes for weight gain purposes; Protein supplement shakes; Protein supplements for animals; Protein supplements; Royal jelly dietary supplements; Soy protein dietary supplements; Topical preparations, namely, testosterone creams for enhancing sexual arousal; Vegan liquid protein supplements; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Vitamin A preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations; Vitamin drops; Vitamin enriched bread for therapeutic purposes; Vitamin enriched chewing gum for medical purposes; Vitamin enriched sparkling water for medical purposes; Vitamin enriched water for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin oils for human consumption; Vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplements; Vitamin tablets; Vitamins and dietary food supplements for animals; Vitamins and vitamin preparations; Vitamins and vitamin supplements, namely, Thiamin, Riboflavin, Niacin, Pyridoxine, Cyanocobalamin, Folacin, Biotin, Vitamin A, Vitamin B-complex, Vitamin C, Vitamin D, Vitamin E, Vitamin K, and multi-vitamins with iron supplements; Vitamins for pets; Vitamins; Weight management supplements; Wheat for use as a dietary supplement; Wheat germ dietary supplements; Wheatgrass for use as a dietary supplement; Whey protein supplements; Yeast dietary supplements; Zinc supplement lozengesACTIVE—
035Wholesale distributorship services featuring generic pharmaceuticals, generic veterinary preparations, and biosimilars; providing advertising, marketing and promotional services for generic pharmaceuticals, generic veterinary preparations, and biosimilars of othersACTIVE—
042Generic pharmaceutical research and development; testing, inspection and research of generic pharmaceuticals, generic veterinary preparations, and biosimilarsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 14, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 14, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 12, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 12, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 12, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 9, 2017DOCKASSIGNED TO EXAMINER—
Mar 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 20, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance